New User? Click here to register

Thoughts on DESTINY-Breast04 for HER2-low metastatic breast cancer.

Text generated by AI based on an exclusive interview, revised and reviewed by

Dr Jean-Philippe MINART, Cannes, France

October 20, 2023

Joseph GLIGOROV
MD, PHD Medical Oncologist, Paris, France

What are the key findins of the PATINA trial for patients with hormone receptor-positive, HER2-positive metastatic breast cancer ?
Hassan GHAZAL
oncologist, Dubai
Role of the breast radiologist in MBC.
Naglaa ABDEL RAZEK
Radiologist, Cairo, Egypt
Role of radiologist in multidisciplinary management of HER2 positive Breast Cancer
Nadia SQALLI HOUSSAINI
De nombreuses nationalités sont représentées à Dubaï, quelles recommandations suivez-vous ? Quel intérêt d'un congrès comme le BCU ?
Kinda DOUAIDARI

Radiologue, Dubai, UAE
Preoperative assessment with FDG Pet CT scan.
9.00 I 9.15

Eric ZERBIB